FreeGuest Editorial Conflicts have killed trust in the system. Advocates must rebuild it December 14, 2018Vol.44 No.46By Frances M. Visco
FreeGuest Editorial Reasons for hope for acute myeloid leukemia patients November 30, 2018Vol.44 No.44By Gwen Nichols
FreeGuest Editorial Trump pricing plans are pretentious, could impede access, and will not help much November 16, 2018Vol.44 No.43By Patricia J. Goldsmith
FreeGuest Editorial When your harmonica player wins the Nobel Prize October 05, 2018Vol.44 No.37By Rachel Humphrey
Guest Editorial The Trump administration “American Patients First” plan to reduce drug prices—Are American cancer patients first? June 15, 2018Vol.44 No.24By Hagop M. Kantarjian and Mary Alma Welch
FreeGuest Editorial Beyond #MeToo:Sexual Harassment in Biomedicine March 09, 2018Vol.44 No.10By Kelly McBride Folkers
FreeGuest Editorial A unique drug for each patient:a paradigm shift in cancer therapy January 19, 2018Vol.44 No.03By Steven A. Rosenberg
Guest Editorial Tobacco companies finally have to say smoking causes cancer December 08, 2017Vol.43 No.45By Cliff Douglas
